other sources of stem cells

Stem cells have revolutionized the field of regenerative medicine, offering new possibilities for treating various diseases and conditions. While cord blood banking has been widely recognized as a valuable source of stem cells, it is important for expecting parents to explore other potential sources as well. As we observe July Cord Blood Awareness Month, it is vital for expecting parents to be aware of alternative sources of stem cells, in addition cord blood, that were also rich in valuable stem cells with remarkable therapeutic potential. These sources include cord tissue, placental cells, and the amniotic membrane. By delving into these alternative sources, we can uncover their unique benefits and contributions to the field of regenerative medicine.

1. Cord Tissue

The umbilical cord tissue, which includes the Wharton’s jelly, is a rich source of mesenchymal stem cells (MSCs). These cells have the ability to differentiate into various types of cells, including bone, cartilage, and fat cells. MSCs from cord tissue have shown promise in regenerative therapies for conditions such as spinal cord injury, heart disease, and autoimmune disorders.

Research studies have highlighted the potential of cord tissue-derived stem cells. For example, a study published in Stem Cells Translational Medicine demonstrated that MSCs derived from cord tissue were effective in treating chronic obstructive pulmonary disease (COPD) in mice. Another study published in Stem Cell Research & Therapy explored the potential of cord tissue MSCs in promoting wound healing and tissue regeneration.

2. Placental Cells

In the world of regenerative medicine, placental stem cells have emerged as a promising source of therapeutic potential. Among these cells, chorionic villi stem cells (CVSCs) found within the placenta have gained considerable attention. CVSCs possess remarkable regenerative properties and are being actively explored in clinical trials for the treatment of several challenging conditions.

One area where CVSCs show promise is in the treatment of Ischaemic stroke, a condition caused by disrupted blood flow to the brain. Clinical trials are investigating the potential of CVSCs to promote tissue repair, regenerate damaged neurons, and improve functional recovery in stroke patients.

Moreover, CVSCs hold great potential for addressing degenerative joint conditions such as osteoarthritis. These stem cells have the ability to differentiate into cartilage cells and promote cartilage regeneration, providing hope for patients suffering from joint pain and disability.

Crohn’s disease, a chronic inflammatory bowel disease, is another condition being targeted by CVSC-based therapies. Preliminary studies have suggested that CVSCs possess anti-inflammatory properties and can modulate the immune response, potentially offering relief to individuals with Crohn’s disease.

Heart disease, a leading cause of mortality worldwide, is also being targeted by CVSC research. Studies have shown that CVSCs can promote angiogenesis (the formation of new blood vessels) and tissue repair in the heart, offering a potential treatment avenue for heart failure and myocardial infarction.

These are just a few examples of the wide range of conditions being explored in clinical trials utilizing CVSCs. Researchers are investigating their potential in addressing conditions such as diabetes, spinal cord injury, liver diseases, and more.

3. Amniotic Membrane

The amniotic membrane, the innermost layer of the placenta, contains specialized cells with regenerative properties. These cells have shown therapeutic potential due to their anti-inflammatory, antimicrobial, and immune-modulating properties. They have been investigated for their potential use in treating conditions such as burns, chronic wounds, and ocular disorders.

A study published in the Journal of Investigative Dermatology reported that amniotic membrane-derived stem cells exhibited promising results in accelerating wound healing and reducing scar formation. Furthermore, another study published in Stem Cells Translational Medicine explored the potential of amniotic membrane-derived cells in treating osteoarthritis, showing positive outcomes in cartilage repair and pain reduction.

When considering the use of cord tissue, placental cells, or amniotic membrane for potential stem cell therapies, it is important to consult with healthcare professionals and stem cell experts. They can provide accurate information about the current state of research and clinical applications.

It’s worth noting that while research on these alternative sources of stem cells is promising, it is still in its early stages, and widespread clinical use is not yet common. However, advancements in stem cell research continue to expand the possibilities for regenerative medicine.

In conclusion, beyond cord blood, expecting parents also have the opportunity to explore other potential sources of stem cells from cord tissue, placental cells, and the amniotic membrane. These sources offer distinct types of stem cells with unique properties and potential therapeutic applications. These alternative sources hold promise for the future of regenerative medicine.

Want to learn more about private cord blood banking?

One of our cord blood banking specialists would be happy to assist you! Simply call us on +9714316613 or send us an email. You can also DOWNLOAD A FREE INFO PACK HERE


  1. Weiss ML et al. “Umbilical cord mesenchymal stem cells: a new source for musculoskeletal regeneration?”. Current Stem Cell Research & Therapy. 2008.
  2. Pasha et al. “Repair of a myocardial infarction by grafting of a patch composed of human umbilical cord blood-derived mesenchymal stem cells in a rat model”. Stem Cells and Development. 2008.
  3. Marongiu F et al. “Isolation of amniotic mesenchymal stem cells”. Current Protocols in Stem Cell Biology. 2010.
  4. Chen L et al. “Amniotic epithelial cells: isolation, characterization, and transplantation for tissue engineering”. Journal of Hunan Normal University (Medical Sciences). 2012.
  5. Liu et al. “Human umbilical cord mesenchymal stem cells: characteristics and therapeutic potential”. Cell Transplantation. 2011.
  6. Niknejad H et al. “Properties of the amniotic membrane for potential use in tissue engineering”. European Cells & Materials. 2008.
  7. Jiang et al. “Human amniotic epithelial cells improve fertility in an intrauterine adhesion mouse model”. Stem Cell Research & Therapy. 2017.
  8. Li et al. “Chorionic villi-derived mesenchymal stem cells possess immunomodulatory properties and improve the prognosis of patients with Crohn’s disease”. Cell Biochemistry and Function. 2019.
  9. Banerjee et al. “Mesenchymal stem cells from fetal chorionic villi: isolation, characterization, and differentiation potential”. Stem Cells and Development. 2010.
  10. Huang et al. “Therapeutic potential of stem cells in cardiac regeneration”. Stem Cells International. 2019.
  11. Golpanian et al. “Allogeneic human mesenchymal stem cell infusions for aging frailty”. Journals of Gerontology: Series A. 2017.
  12. Lu et al. “Chorionic villi-derived mesenchymal stem cells differentiate into neural progenitor cells and promote neuroregeneration in a rat model of ischemic stroke”. Stem Cell Research & Therapy. 2019.